性别与肝性脑病患者肠道微生物组成和功能的差异相关
该横断面研究纳入761人(619例肝硬化患者和142名对照),用16s rRNA测序和微生物功能分析比较男女在肝硬化及肝性脑病(HE)不同治疗下的粪便微生物差异。发现男女在微生物组成和功能上存在差异,且差异随疾病进展和治疗不同而变化,可能与HE治疗反应不同有关。
要点
- 女性中对照组与全部肝硬化、对照组与无HE组的调整AUC高于男性。
- 男性中无HE组与HE-Rif组的调整AUC高于女性。
- 男性在HE-Lac组乳杆菌科升高,而在HE-Rif组降低。
核心结论
- 肝硬化男女患者肠道微生物功能和组成存在差异,可能涉及对HE治疗的不同反应。
- 需要进一步研究将这些差异与性别特异性结局联系起来。
研究设计与样本
- 横断面研究,纳入761人,包括619例肝硬化患者(466男、153女)和142名对照(92男、50女)。
- 进行粪便16s rRNA测序和微生物功能分析,用随机森林分类器比较组间差异。
主要发现
- 对照组与全部肝硬化、对照组与无HE组的PPI/年龄调整AUC在女性中高于男性。
- 无HE组与HE-Rif组的调整AUC在男性中高于女性。
- 男性与女性在全部肝硬化、无HE和HE-Lac组有差异,但在HE-Rif组无差异。
- 无论性别,随疾病进展,自体菌群减少而致病菌增加。
- 男性在HE-Lac组乳杆菌科升高,在HE-Rif组降低,韦荣球菌科同样降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Altered microbiota can affect the gut-liver-brain axis in cirrhosis and hepatic encephalopathy (HE), but the impact of sex on these changes is unclear. We aimed to determine differences in fecal microbiota composition/functionality between men and women with cirrhosis and HE on differing treatments. METHODS: Cross-sectional stool microbiome composition (16s rRNA sequencing) and microbial functional analyses were performed in men and women with cirrhosis, and controls. Patients with HE on rifaximin+lactulose (HE-Rif), patients with HE on lactulose only (HE-Lac) and those with cirrhosis without HE (No-HE) were compared to controls using random forest classifier. Men and women were also compared. RESULTS: A total of 761 individuals were included, 619 with cirrhosis (466 men, 153 women) and 142 controls (92 men, 50 women). Men were older and more frequently used proton pump inhibitors (PPIs), but model for end-stage liver disease score, No-HE (n = 319), HE-lac (n = 130) and HE-Rif (n = 170) proportions were similar. PPI/age-adjusted AUC of differentiation between controls vs. all cirrhosis, and controls vs. No-HE were higher within women than men, but the adjusted AUC for No-HE vs. HE-Rif was higher in men. Control vs. HE-Rif differentiation was similar across sexes. Men vs. women were different in all cirrhosis, No-HE and HE-Lac but not HE-Rif on PERMANOVA and AUC analyses. Autochthonous taxa decreased and pathobionts increased with disease progression regardless of sex. In men, Lactobacillaceae were higher in HE-Lac but decreased in HE-Rif, along with Veillonellaceae. Pathways related to glutamate and aromatic compound degradation were higher in men at all stages. Degradation of androstenedione, an estrogenic precursor, was lower in men vs. women in HE-Rif, likely enhancing feminization. CONCLUSIONS: There are differences in gut microbial function and composition between men and women with cirrhosis, which could be implicated in differential responses to HE therapies. Further studies linking these differences to sex-specific outcomes are needed. LAY SUMMARY: Patients with cirrhosis develop changes in their brain function, and men often develop feminization with disease progression. However, the interaction between sex, microbiota and disease severity is unclear. We found that as disease progressed in men, their microbial composition began to approach that observed in women, with changes in specific microbes that are associated with male hormone metabolism.
引用
- Saboo K, Shamsaddini A, Iyer MV, et al. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy. J Hepatol. 2020. PMID: 32679299. doi:10.1016/j.jhep.2020.06.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。